NCT00825617View on ClinicalTrials.gov

Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 1996

Primary Completion Date

October 31, 1999

Study Completion Date

June 30, 2000

Conditions
Turner Syndrome
Interventions
DRUG

Hormone replacement therapy

Women with TS were treated with oral hormone substitution consisting of 2 mg 17β-estradiol/day for days 1-12, 2 mg 17β-estradiol/day and 1 mg norethisterone acetate/day for days 13-22 and 1 mg 17β-estradiol/day for days 23-28 (Trisekvens, Novo Nordisk A/S, Bagsværd, Denmark)

Trial Locations (1)

8000

Medical department M and Investigational Laboratories, Aarhus C

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT00825617 - Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy | Biotech Hunter | Biotech Hunter